回盛生物: 关于提前赎回“回盛转债”的第十三次提示性公告

Core Viewpoint - Wuhan Huirong Biological Technology Co., Ltd. has announced the mandatory redemption of its convertible bonds at a price of 100.64 yuan per bond, urging bondholders to convert their bonds into shares within the specified period due to significant differences between the market price and the redemption price [1][2] Group 1: Convertible Bond Overview - The company issued 7 million convertible bonds on December 17, 2021, with a total amount of 70 million yuan and a maturity of 6 years [2] - The initial conversion price was set at 28.32 yuan per share, which was adjusted to 27.99 yuan per share after the 2021 annual equity distribution [2][4] - The conversion price has undergone several adjustments, with the latest being 15.00 yuan per share as of August 2024 [6][7] Group 2: Redemption Conditions - The mandatory redemption was triggered as the company's stock price met the condition of being at least 130% of the conversion price (19.50 yuan) for at least 15 trading days within a 30-day period [1][7] - The redemption price is calculated to be 100.64 yuan per bond, which includes accrued interest [8] Group 3: Redemption Process - The redemption will be executed for all bondholders registered with the China Securities Depository and Clearing Corporation by May 20, 2025 [9] - The company will publish announcements regarding the redemption results and the delisting of the convertible bonds from the Shenzhen Stock Exchange [9] Group 4: Management Transactions - During the six months prior to the redemption conditions being met, the company's senior management reduced their holdings of the convertible bonds from 21,120 to 60 bonds [10]